RHPN2 and prostate carcinoma: Collectively, our results suggest that exosome-mediated transfer of miR-205 from hBMSCs to prostate cancer cells suppresses proliferation, migration, and invasion of prostate cancer cells via downregulation of RHPN2, ultimately attenuating progression of prostate cancer.